Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice
Purpose: Anthrax Lethal Toxin (LeTx), composed of protective antigen and lethal factor, catalytically cleaves mitogen-activated protein kinase (MAPK) kinases and inhibits the MAPK signaling pathways. The majority of metastatic melanomas possess the V599E BRAF mutation, which constitutively activates...
Saved in:
| Main Author: | Abi-Habib, Ralph J. (author) |
|---|---|
| Other Authors: | Singh, Ravibhushan (author), Leppla, Stephen H. (author), Greene, John J. (author), Ding, Yan (author), Berghuis, Bree (author), Duesbery, Nicholas S. (author), Frankel, Arthur E. (author) |
| Format: | article |
| Published: |
2006
|
| Online Access: | http://hdl.handle.net/10725/2735 http://dx.doi.org/ 10.1158/1078-0432.CCR-06-2019 http://www.ncbi.nlm.nih.gov/pubmed/17189417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sensitivity of colorectal cancer cells to the recombinant Anthrax lethal toxin and the Urokinase-activated Anthrax lethal toxin. (c2014)
by: Kasbo, Zein Jean
Published: (2014) -
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
by: Abi-Habib, Ralph J.
Published: (2005) -
Cytotoxicity of Anthrax Lethal Toxin to Human Acute Myeloid Leukemia Cells Is Nonapoptotic and Dependent on Extracellular Signal-Regulated Kinase 1/2 Activity
by: Abi-Habib, Ralph J.
Published: (2013) -
A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types
by: Abi-Habib, Ralph J.
Published: (2006) -
Effect of Anthrax Lethal Toxin on Activation of MAPK Pathway and Autophagy in AML Cell Lines
by: Soukarieh, Rania
Published: (2021)